Longitudinal assessment of circulating tumor DNA throughout multi-modality therapy for esophageal and rectal cancer: A potential biomarker for non-operative management
CtDNA levels associate with clinical outcomes throughout multi-modality therapy in esophageal and rectal cancer and may serve as a biomarker for treatment response in clinical trials for non-operative management.